These findings position STMN1 and PRDX1 not merely as potential predictive indicators for hepatocellular carcinoma (HCC) prognosis, but more critically, as central regulators governing its metabolic reprogramming and immune modulation. The gene discussed is PRDX1; the disease is hepatocellular carcinoma.